153 related articles for article (PubMed ID: 18224273)
1. Dense deposit disease and the factor H H402 allele.
Lau KK; Smith RJ; Kolbeck PC; Butani L
Clin Exp Nephrol; 2008 Jun; 12(3):228-32. PubMed ID: 18224273
[TBL] [Abstract][Full Text] [Related]
2. Childhood-onset dense deposit disease: a rare cause of proteinuria.
Taranta-Janusz K; Wasilewska A; Szynaka B
Ir J Med Sci; 2014 Sep; 183(3):455-9. PubMed ID: 24338037
[TBL] [Abstract][Full Text] [Related]
3. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).
Abrera-Abeleda MA; Nishimura C; Smith JL; Sethi S; McRae JL; Murphy BF; Silvestri G; Skerka C; Józsi M; Zipfel PF; Hageman GS; Smith RJ
J Med Genet; 2006 Jul; 43(7):582-9. PubMed ID: 16299065
[TBL] [Abstract][Full Text] [Related]
4. Gene polymorphism of complement factor H in a Turkish patient with membranoproliferative glomerulonephritis type II.
Sozeri B; Mir S; Berdeli A; Dincel N; Sarsik B
Iran J Kidney Dis; 2012 Mar; 6(2):149-53. PubMed ID: 22388616
[TBL] [Abstract][Full Text] [Related]
5. Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation.
Leroy V; Fremeaux-Bacchi V; Peuchmaur M; Baudouin V; Deschênes G; Macher MA; Loirat C
Pediatr Nephrol; 2011 Mar; 26(3):419-24. PubMed ID: 21188423
[TBL] [Abstract][Full Text] [Related]
6. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
Servais A; Noël LH; Roumenina LT; Le Quintrec M; Ngo S; Dragon-Durey MA; Macher MA; Zuber J; Karras A; Provot F; Moulin B; Grünfeld JP; Niaudet P; Lesavre P; Frémeaux-Bacchi V
Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
[TBL] [Abstract][Full Text] [Related]
7. Acute renal failure in dense deposit disease: complete recovery after combination therapy with immunosuppressant and plasma exchange.
Krmar RT; Holtbäck U; Linné T; Berg UB; Celsi G; Söderberg MP; Wernerson A; Szakos A; Larsson S; Skattum L; Bárány P
Clin Nephrol; 2011 Feb; 75 Suppl 1():4-10. PubMed ID: 21269585
[TBL] [Abstract][Full Text] [Related]
8. A CHILD WITH DENSE DEPOSIT DISEASE AND DECREASED CLASSIC COMPLEMENT PATHWAY ACTIVITY.
Trutin I; Oletić L; Galešić Ljubanović D; Turudić D; Milošević D
Acta Clin Croat; 2021 Mar; 60(1):141-145. PubMed ID: 34588735
[TBL] [Abstract][Full Text] [Related]
9. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[TBL] [Abstract][Full Text] [Related]
10. [An approach to research on nephritic factor and membranoproliferative glomerulonephritis].
Ohi H
Nihon Jinzo Gakkai Shi; 2012; 54(7):1006-15. PubMed ID: 23234212
[TBL] [Abstract][Full Text] [Related]
11. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
Licht C; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
[TBL] [Abstract][Full Text] [Related]
12. Novel factor H mutation associated with familial membranoproliferative glomerulonephritis type I.
Alfandary H; Davidovits M
Pediatr Nephrol; 2015 Dec; 30(12):2129-34. PubMed ID: 26289290
[TBL] [Abstract][Full Text] [Related]
13. Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
Sethi S; Sukov WR; Zhang Y; Fervenza FC; Lager DJ; Miller DV; Cornell LD; Krishnan SG; Smith RJ
Am J Kidney Dis; 2010 Nov; 56(5):977-82. PubMed ID: 20832153
[TBL] [Abstract][Full Text] [Related]
14. Remission of membranoproliferative glomerulonephritis type I with the use of tacrolimus.
Haddad M; Lau K; Butani L
Pediatr Nephrol; 2007 Oct; 22(10):1787-91. PubMed ID: 17609987
[TBL] [Abstract][Full Text] [Related]
15. Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis.
Montes T; Goicoechea de Jorge E; Ramos R; Gomà M; Pujol O; Sánchez-Corral P; Rodríguez de Córdoba S
Mol Immunol; 2008 May; 45(10):2897-904. PubMed ID: 18336910
[TBL] [Abstract][Full Text] [Related]
16. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
Holle J; Berenberg-Goßler L; Wu K; Beringer O; Kropp F; Müller D; Thumfart J
Pediatr Nephrol; 2018 Dec; 33(12):2289-2298. PubMed ID: 30238151
[TBL] [Abstract][Full Text] [Related]
17. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
[TBL] [Abstract][Full Text] [Related]
18. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
Okuda Y; Ishikura K; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Fukuzawa R; Ogata K; Honda M
Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
[TBL] [Abstract][Full Text] [Related]
19. [Clinical approach to primary membranoproliferative glomerulonephritis].
Fakhouri F
Nephrol Ther; 2016 Apr; 12 Suppl 1():S65-9. PubMed ID: 26972096
[TBL] [Abstract][Full Text] [Related]
20. Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients.
Nasr SH; Valeri AM; Appel GB; Sherwinter J; Stokes MB; Said SM; Markowitz GS; D'Agati VD
Clin J Am Soc Nephrol; 2009 Jan; 4(1):22-32. PubMed ID: 18971369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]